A study to assess vaccine-induced humoral and cell-mediated immunity at 6 months after completion of two doses of BNT162b2 vaccination
Latest Information Update: 11 Apr 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 11 Apr 2022 New trial record
- 29 Mar 2022 Results published in the Vaccine